https://novoholdings.dk/news/novo-holdings-leads-100m-series-a-financing-to-advance-gene-therapies-for-blinding-diseases
Novo Holdings leads $100M Series A Financing to Advance Gene
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsseries aleadsfinancingadvance
https://novoholdings.dk/news/novo-holdings-launches-portfolio-company-booster-therapeutics-to-advance-new-class-of-small-molecule-proteasome-activator-therapeutics
Novo Holdings Launches Portfolio Company Booster Therapeutic
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsportfolio companylaunchesboostertherapeutic
https://novoholdings.dk/news/novo-holdings-boston-office-named-a-2024-best-place-to-work-by-the-boston-business-journal
Novo Holdings Boston office named a 2024 Best Place to Work
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsboston officenamed
https://www.prnewswire.com/news/novo-holdings/
Novo Holdings News and Press Releases | PR Newswire
news and press releasesnovo holdingsnewswire
https://novoholdings.dk/news/novo-holdings-portfolio-company-kate-farms-acquired-by-danone
Novo Holdings portfolio company Kate Farms acquired by Danon
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsportfolio companykate farmsacquired
https://www.biopharmaapac.com/analysis/116/5658/novo-holdings-completes-catalent-acquisition-novo-nordisk-secures-strategic-manufacturing-sites.html
Novo Holdings Completes Catalent Acquisition; Novo Nordisk Secures Strategic Manufacturing Sites
Balancing Short-Term Financial Challenges with Long-Term Strategic Gains
novo holdingscompletescatalentacquisitionnordisk
https://www.sensamarket.com/institutional-investor/manager/0001388325-novo-holdings-as
Novo Holdings A/S Stock Trades - Novo Holdings A/S 13F
Novo Holdings A/S reported 72 holdings with total value $1.29T as of Q4 2025. Top holdings included
novo holdingsstocktrades
https://novoholdings.dk/news/novo-holdings-joins-usd-40-8-million-series-c-extension-round-for-doctor-anywhere-a-tech-led-healthcare-provider-based-in-singapore
Novo Holdings joins USD 40.8 million Series C extension roun
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsseries cjoinsusd
https://novoholdings.dk/news/novo-holdings-leads-100-million-series-c-financing-of-asceneuron-to-advance-groundbreaking-therapy-for-alzheimer-s-disease
Novo Holdings leads $100 million Series C financing of Ascen
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsseries cleadsmillionfinancing
https://ecp.crai.com/case/ec-unconditionally-approves-16-5bn-acquisition-of-catalent-by-novo-holdings/
Novo Holdings/Novo Nordisk/Catalent - Charles River Associates
Sep 2, 2025 - On 6 December 2024, the European Commission unconditionally cleared Novo Holdings acquisition of Catalent, a contract development and manufacturing...
novo holdingscharles rivernordiskcatalentassociates
https://novoholdings.dk/news/novo-holdings-leads-100m-series-a-financing-to-advance-gene-therapies-for-blinding-diseases
Novo Holdings leads $100M Series A Financing to Advance Gene
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsseries aleadsfinancingadvance
https://novoholdings.dk/news/novo-holdings-launches-portfolio-company-booster-therapeutics-to-advance-new-class-of-small-molecule-proteasome-activator-therapeutics
Novo Holdings Launches Portfolio Company Booster Therapeutic
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsportfolio companylaunchesboostertherapeutic
https://novoholdings.dk/news/novo-holdings-boston-office-named-a-2024-best-place-to-work-by-the-boston-business-journal
Novo Holdings Boston office named a 2024 Best Place to Work
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsboston officenamed
https://denovo.novoholdings.dk/
de novo by Seed Investments team (@Novo Holdings) | Substack
a biotech blog by the Seed Investments team of Novo Holdings. Click to read de novo by Seed Investments team (@Novo Holdings), by Seeds' team (Novo Holdings),...
de novoinvestments teamseedholdingssubstack
https://www.prnewswire.com/news/novo-holdings/
Novo Holdings News and Press Releases | PR Newswire
news and press releasesnovo holdingsnewswire
https://novoholdings.dk/news/changes-to-the-board-of-novo-holdings
Changes to the Board of Novo Holdings
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
to thechangesboardnovoholdings
https://novoholdings.dk/
Novo Holdings
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novoholdings
https://siliconvalleyjournals.com/avencell-raises-112-million-in-series-b-funding-led-by-novo-holdings/
AvenCell Raises $112 Million in Series B Funding Led by Novo Holdings
Oct 22, 2024 - AvenCell Therapeutics, Inc., a clinical-stage cell therapy company specializing in innovative CAR-T cell therapies, has announced the successful completion of
series b funding
https://pharma.economictimes.indiatimes.com/news/pharma-industry/regulatory-conditions-on-novo-holdings-16-5-bln-catalent-deal-fulfilled-companies-say/116331454
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say, ETPharma
Novo Holdings: Novo Nordisk said that the acquisition is expected to have a mid single-digit negative impact on the company's operating profit growth for 2025,...
https://novoholdings.dk/news/novo-holdings-portfolio-company-kate-farms-acquired-by-danone
Novo Holdings portfolio company Kate Farms acquired by Danon
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
novo holdingsportfolio companykate farmsacquired